Literature DB >> 8534762

Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells.

X Zhu1, M Imamura, S Hashino, J Tanaka, S Kobayashi, H R Tao, M Asaka, M Kasai, T Matsudaira, S Asano.   

Abstract

Immunosuppressants cyclosporin A (CsA), FK506, and KM2210 modulated colony formations of murine hematopoietic progenitor cells. In a 4-h treatment with CsA, 10 micrograms/ml increased the formation of colony-forming units of mixed lineages (CFU-Mix) but decreased the formation of highly proliferative potential colony-forming units (CFU-HPP); 1 microgram/ml of CsA increased the formations of CFU-HPP, CFU-Mix, and colony-forming units of granulocytes/macrophages (CFU-GM); 0.1 microgram of CsA increased the formation of CFU-Mix and burst-forming units of erythroid lineage (BFU-E). Lower doses of CsA appeared to induce an increase in various colony formations. FK506 increased CFU-HPP and CFU-Mix formations at lower doses. Another immunosuppressant, KM2210, increased CFU-HPP and CFU-GM formations but decreased CFU-Mix and BFU-E formations. In a 24-h treatment, 10 micrograms/ml and 1 microgram/ml of CsA inhibited all the colony formations, but 0.1 microgram/ml of CsA increased CFU-Mix, CFU-GM, and BFU-E formations. Similarly, 100 ng/ml and 10 ng/ml of FK506 decreased all the colony formations but 1 ng/ml of FK506 increased CFU-HPP and CFU-GM formations. KM2210 inhibited all the colony formations. These findings showed that lower doses of CsA and FK506 appeared to increase the colony formations, although higher doses of these drugs decreased the colony formations, similar to the findings in a 4-h treatment. On the other hand, KM2210 showed opposing effects on colony formation with 4-h and 24-h treatments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8534762     DOI: 10.1007/bf01697983

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  15 in total

Review 1.  FK506 and cyclosporin, molecular probes for studying intracellular signal transduction.

Authors:  J Liu
Journal:  Immunol Today       Date:  1993-06

2.  Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.

Authors:  N Yoshimura; S Matsui; T Hamashima; T Oka
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

3.  Detection of primitive macrophage progenitor cells in mouse bone marrow.

Authors:  T R Bradley; G S Hodgson
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

4.  Enhancing effect of cyclosporins A and G on bone marrow colony formation.

Authors:  Y Kalechman; B Sredni; R R Caspi; R B Nussenblatt
Journal:  Exp Hematol       Date:  1990-11       Impact factor: 3.084

5.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

Authors:  J Liu; J D Farmer; W S Lane; J Friedman; I Weissman; S L Schreiber
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

6.  Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.

Authors:  C W Han; M Imamura; S Hashino; X Zhu; J Tanaka; K Imai; T Matsudaira; S Asano
Journal:  Bone Marrow Transplant       Date:  1995-05       Impact factor: 5.483

7.  A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells.

Authors:  S C Wang; P A Morel; Q Wang; M L Jordan; R L Simmons; D J Tweardy
Journal:  Transplantation       Date:  1993-10       Impact factor: 4.939

8.  Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA.

Authors:  J Friedman; I Weissman
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

9.  Effects of 15-deoxyspergualin in vitro and in vivo on cytokine gene expression.

Authors:  X Zhu; M Imamura; J Tanaka; C W Han; S Hashino; K Imai; M Asano; A Nakane; T Minagawa; M Kobayashi
Journal:  Transplantation       Date:  1994-11-27       Impact factor: 4.939

10.  In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietin.

Authors:  M Imamura; M Han; S Hashino; H Kobayashi; K Imai; S Kobayashi; J Tanaka; X Zhu; M Kobayashi; Y Fujii
Journal:  Transplantation       Date:  1994-07-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.